The Therapeutic Potential of Neural Stem Cell in Ischemic Stroke: A Systematic Review
##plugins.pubIds.doi.readerDisplayName##:
https://doi.org/10.19166/med.v14i3.10165关键词:
Ischemic stroke, Neural stem cells, Preclinical models, Regenerative therapy摘要
Background: Ischemic stroke remains a leading cause of disability and mortality worldwide, with over 12 million new cases annually and limited treatment options confined to narrow therapeutic windows. Neural stem cells (NSCs) have emerged as a promising therapeutic avenue due to their ability to self-renew, differentiate into all neural lineages, and exert paracrine effects that modulate inflammation and promote neurogenesis. Preclinical studies have demonstrated functional improvements of up to 60% in animal stroke models, but a systematic evaluation of these findings is needed to inform future clinical applications.
Methods: A systematic review was conducted following PRISMA 2020 guidelines. Databases searched included PubMed, EMBASE, and Scopus, covering literature up to May 8, 2025. Inclusion criteria comprised in vivo preclinical studies investigating NSC transplantation in animal models of ischemic stroke with at least one neurological, infarct, or histological outcome. Data extraction and risk of bias assessment (ROBINS-I) were independently performed by three reviewers. Due to study heterogeneity, a narrative synthesis was undertaken.
Result: Eight studies met the inclusion criteria. NSC therapy improved neurological recovery in over 80% of cases, reduced infarct volume by up to 40%, and downregulated pro-inflammatory and apoptotic markers. Benefits were dose- and timing-dependent, with intracerebral and intravenous routes demonstrating variable efficacy. One study reported tumorigenicity, highlighting the need for safety profiling.
Conclusions: Preclinical evidence supports the therapeutic potential of NSCs in ischemic stroke through neuroprotective and neurorestorative mechanisms. High-certainty findings justify continued investigation in clinical trials to refine dosing, delivery, and safety protocols.
参考
1. Lui F, Hui C, Mahammed Z, Suheb K, Patti L. Ischemic Stroke. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499997/
2. Kataria S, Patel U, Yabut K, Patel J, Patel R, Patel S, et al. Recent advances in management of neuropathic, nociceptive, and chronic pain: a narrative review with focus on nanomedicine, gene therapy, stem cell therapy, and newer therapeutic options. Curr Pain Headache Rep. 2024;28(5):321–33. https://doi.org/10.1007/s11916-024-01227-5
3. Tang X, Deng P, Li L, He Y, Wang J, Hao D, et al. Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases. Stem Cell Res Ther. 2024;15(1):482. https://doi.org/10.1186/s13287-024-04089-1
4. Zhang GL, Zhu ZH, Wang YZ. Neural stem cell transplantation therapy for brain ischemic stroke: review and perspectives. World J Stem Cells. 2019 Oct 26;11(10):817–30. https://doi.org/10.4252/wjsc.v11.i10.817
5. Kalladka D, Sinden J, Pollock K, Haig C, McLean J, Smith W, et al. Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet. 2016;388(10046):787–96. https://doi.org/10.1016/s0140-6736(16)30513-x
6. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71. https://doi.org/10.1136/bmj.n71
7. Wu Y, Yang LW, Zhai XY, Liu JC. A comparison of intracerebral transplantation of RMNE6 cells and MSCs on ischemic stroke models. Neurol India. 2019;67(6):1482. https://doi.org/10.4103/0028-3886.273641
8. Hribljan V, Salamon I, Đemaili A, Alić I, Mitrečić D. Transplantation of neural stem cells in the mouse model of ischemic brain stroke and expression of genes involved in programmed cell death. Croat Med J. 2018 Oct 31;59(5):203–12. https://doi.org/10.3325/cmj.2018.59.203
9. Hassani Z, O’Reilly J, Pearse Y, Stroemer P, Tang E, Sinden J, et al. Human neural progenitor cell engraftment increases neurogenesis and microglial recruitment in the brain of rats with stroke. PLoS One. 2012;7(11):e50444. https://doi.org/10.1371/journal.pone.0050444
10. Stroemer P, Patel S, Hope A, Oliveira C, Pollock K, Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair. 2009 Nov;23(9):895–909. https://doi.org/10.1177/1545968309335978
11. Lisjak D, Alić I, Šimunić I, Mitrečić D. Transplantation of neural stem cells improves recovery of stroke-affected mice and induces cell-specific changes in GSDMD and MLKL expression. Front Mol Neurosci. 2024;17:1439994. https://doi.org/10.3389/fnmol.2024.1439994
12. Shen CC, Lin CH, Yang YC, Chiao MT, Cheng WY, Ko JL. Intravenous implanted neural stem cells migrate to injury site, reduce infarct volume, and improve behavior after cerebral ischemia. Cell Neurochem Res. 2010 Aug 1;7(3):167–79. https://doi.org/10.2174/156720210792231822
13. Huang L, Wong S, Snyder EY, Hamblin MH, Lee JP. Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury. Stem Cell Res Ther. 2014 Nov 23;5(6):129. https://doi.org/10.1186/scrt519
14. Cheng Y, Zhang J, Deng L, Johnson NR, Yu X, Zhang N, et al. Intravenously delivered neural stem cells migrate into ischemic brain, differentiate and improve functional recovery after transient ischemic stroke in adult rats. Int J Clin Exp Pathol. 2015;8(3):2928–36. https://pmc.ncbi.nlm.nih.gov/articles/PMC4440110/
15. Kaminska A, Radoszkiewicz K, Rybkowska P, Wedzinska A, Sarnowska A. Interaction of neural stem cells (NSCs) and mesenchymal stem cells (MSCs) as a promising approach in brain study and nerve regeneration. Cells. 2022 Apr 26;11(9):1464. https://doi.org/10.3390/cells11091464
16. Boese AC, Eckert A, Hamblin MH, Lee JP. Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains. Exp Neurol. 2020 Jul;329:113275. https://doi.org/10.1016/j.expneurol.2020.113275
17. Cheng Z, Zhu W, Cao K, Wu F, Li J, Wang G, et al. Anti-inflammatory mechanism of neural stem cell transplantation in spinal cord injury. Int J Mol Sci. 2016 Aug 23;17(9):1380. https://doi.org/10.3390/ijms17091380
18. Rust R, Nih LR, Liberale L, Yin H, El Amki M, Ong LK, et al. Brain repair mechanisms after cell therapy for stroke. Brain. 2024 Oct 3;147(10):3286–305. https://doi.org/10.1093/brain/awae204
19. Liu W, Yang M, Wang N, Liu X, Wang C, Shi K, et al. Intracalvariosseous injection: an approach for central nervous system drug delivery through skull bone marrow with a preclinical research in stroke. EBioMedicine. 2025 Feb;112:105568. https://doi.org/10.1016/j.ebiom.2025.105568
20. Tang YH, Ma YY, Zhang ZJ, Wang YT, Yang GY. Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke. CNS Neurosci Ther. 2015 Apr;21(4):337–47. https://doi.org/10.1111/cns.12386
##submission.downloads##
已出版
##submission.howToCite##
期
栏目
##submission.license##
##submission.copyrightStatement##
##submission.license.cc.by-sa4.footer##Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
